PubRank
Search
About
Laurie Gordon
Author PubWeight™ 16.70
‹?›
Top papers
Rank
Title
Journal
Year
PubWeight™
‹?›
1
A genetic variation map for chicken with 2.8 million single-nucleotide polymorphisms.
Nature
2004
5.24
2
A comprehensive catalog of human KRAB-associated zinc finger genes: insights into the evolutionary history of a large family of transcriptional repressors.
Genome Res
2006
2.71
3
Differential expansion of zinc-finger transcription factor loci in homologous human and mouse gene clusters.
Genome Res
2003
1.77
4
Evolutionary expansion and divergence in the ZNF91 subfamily of primate-specific zinc finger genes.
Genome Res
2006
1.54
5
Fragment-based discovery of bromodomain inhibitors part 2: optimization of phenylisoxazole sulfonamides.
J Med Chem
2012
1.42
6
Identification of a novel series of BET family bromodomain inhibitors: binding mode and profile of I-BET151 (GSK1210151A).
Bioorg Med Chem Lett
2012
1.24
7
Configuration of a high-content imaging platform for hit identification and pharmacological assessment of JMJD3 demethylase enzyme inhibitors.
J Biomol Screen
2012
0.85
8
Bicyclic heteroarylpiperazines as selective brain penetrant 5-HT6 receptor antagonists.
Bioorg Med Chem Lett
2005
0.79
9
Pharmacological profile of antipsychotics at monoamine receptors: atypicality beyond 5-HT2A receptor blockade.
CNS Neurol Disord Drug Targets
2006
0.78
10
In vitro and in vivo characterization of the novel GABAB receptor positive allosteric modulator, 2-{1-[2-(4-chlorophenyl)-5-methylpyrazolo[1,5-a]pyrimidin-7-yl]-2-piperidinyl}ethanol (CMPPE).
Neuropharmacology
2011
0.78
11
Ketamine Abuse Syndrome: Hepatobiliary and Urinary Pathology Among Adolescents in Flushing, NY.
Pediatr Emerg Care
2017
0.77
12
Acylglycinamides as inhibitors of glycine transporter type 1.
Bioorg Med Chem Lett
2011
0.75
13
Discovery of a Potent, Cell Penetrant, and Selective p300/CBP-Associated Factor (PCAF)/General Control Nonderepressible 5 (GCN5) Bromodomain Chemical Probe.
J Med Chem
2017
0.75
14
Studies on a series of potent, orally bioavailable, 5-HT(1) receptor ligands--part II.
Bioorg Med Chem Lett
2008
0.75